Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is what I am looking for, too. I think there is a lot of life left in this stock and we will see if it has legs. I like it as a longer term stock and even though it might be volatile - I think it runs to 1.50-2.00 in the next couple months.
Not dead yet folks!
I expect this to be volatile today - but I think there is something up here. Strong buying out of nowhere - I think information is going out. Someone on here said yesterday that they talked to IR and there was a successful resolution to their 8K. That was the reason for the major drop in the first place. Hang on to your hat and strap in for the ride.
Not dead yet folks!
I expect this to be volatile today - but I think there is something up here. Strong buying out of nowhere - I think information is going out. Someone on here said yesterday that they talked to IR and there was a successful resolution to their 8K. That was the reason for the major drop in the first place. Hang on to your hat and strap in for the ride.
This isn't flying up for no reason - resolving the 8K is HUGE!!!
Tomorrow should be huge too!!
Volume is starting to really come in as the word gets out!!!
Geez -- I was going to buy a bunch on the dip down to .20 yesterday and didn't pull the trigger. Wish I had. Will be watching it closely today.
Pretty good rise into the close - we shall see if this has legs tomorrow. Put this one on your watch list and get ready to load up on it if there is something going on.
Agreed Couch. I think we test .23 very soon - there is a good wave of momentum running here and I think we can keep it going, too. Too many good things are happening here and I think we have a real turnaround story.
SOLID DAY FOR THE LONGS!!
It was another big day for us with a solid gain, but I especially liked climbing over that .20 wall and going beyond. We have a long ways to go, but I like the direction we are going and I am looking for .28 near term on this.
Hang in there longs and enjoy the run!
Rodman and Renshaw give it a buy!
Price Target 6.00 a share. I am in!
Good volume yesterday.
Over the wall -- come on boys - let's drive it over .20!
Well let's tear down that .20 wall today and keep moving up - it can and will be done - let's rock!!
WILL WE TAKE OUT THE .20 BARRIER TODAY??
It looks like some good news has been coming out from ELTP the last couple days - nice upward trend here! Can it continue over the .20 wall today? I am thinking we take out the wall and keep climbing upward from here. I like what I see here. Thoughts??
ADMP is NOT done!!
Just read the Barron's article again - giving it a 10.00 target within the next 12 months. MYL is expected to retain a big piece of the pie with the generic drug, but given a chance, ADMP will cut into it. Even a small piece of 5-10 pct will give them a 50-100 million share of the pie. That's a pretty big piece and I bet they could do a lot more than that, too if they keep their prices in line with the generic drug.
This is not over yet folks, not by any means. This is going to rise up fast after that initial wave of panic subsides -- really you had to expect MYL to do this to be able to compete. Nothing is really different from a day ago and I am going strong with the Barron's article.
Fundamentals unchanged! Great buying opportunity
MYL is putting out their generic brand for half price - this does not change the fact ADMS is moving in. As Barron's states - even if they capture 5-10 pct of this market - they will make 50-100 million dollars. They should be able to capture a lot more than that!!! At 3.20 this is a steal!!
Wow -- I thought that was satire or a joke at first. I can't believe the audacity of some greedy greedy people. It would be fun to short MYL to oblivion and I think that will happen as they lose their market share. I really hope ADMP can get in there and give them some competition. The FDA needs to fast track these guys to get this on the market as fast as possible and lower the price of this life saving drug.
ADMP -- may you rise on Monday and beyond but I hope you all the success in the world. The FDA should be ashamed of themselves for putting the brakes on this earlier and giving MYL the monopoly it enjoys.
GO ADMP GO!!!
It should be a fun one to watch for tomorrow, for sure. Incidentally, Barron's also wrote up an article on MYL giving it a SELL rating as they are in disarray and will probably see others such as ADMP eat into their sales bigtime.
This will be a big swing trade tomorrow as traders will try to play some big swings, but those who are patient will see huge rewards if they hang on for the ride. I think 10.00 within the next 12 months is very attainable. Cheers!
ADMP -- Great Buy
1. Barron's article presents strong points - calling it a buy with a target of 10.00 in 12 months.
2. EpiPen is a major news story - getting major press.
3. Fills a strong need and is a good alternative to a product that is overpriced. Congress is on top of it.
4. Strong buying last few hours on Friday as public awareness increases. Any sell-offs should be met with people buying on the dips. Should get a nice carry-over Monday. If it pops early, should see some profit taking - but I am predicting that dips will be met with additional rounds of buying.
Should see some strong runs with some volatility, but the people who hang in there should be rewarded. GLTA - if you aren't in - keep a close eye on it!!
Keeping a close eye on this one! Could Take off!
1. Analyst Needham believes this company will not just survive but thrive. Upgraded to buy and raised target from .50 to .65.
2. Off a multiple bottom formation (bullish)
3. Strong volume Friday (5x normal volume)
4. Share price at .37 could see a nice bump as the company gets their act together and moves forward. If they can control their costs, this could really fly.
I will be watching closely on Monday, particularly the volume to see if cash continues to get funneled in. Good luck to us all!
Out for now -- will buy back in after it bottoms out. I love this game!!!
BOO - YAH!!!!!!!
You are wrong on this one, Jake.
#1 - 29 per cent gain in one day is NOT overpumped if the news has substance. This isn't fluff - it's 60 million upfront and up to 350 million if it reaches various milestones.
#2 - Shingles vaccine alone with a 97 per cent effective rate will bring in huge revenue streams.
#3 - Several upgrades all at 10.00 or more coming in Friday. They all know how big of a deal this is.
#4 - You can expect more upgrades as this news digests. One upgrade came in when the company was at 4.91 on Friday and heavy buying took it all the way back up to 5.50 range immediately.
#5 - Afterhours, Jimmy Cramer is telling everyone this is the last chance to get in at these prices. He could not contain his excitement when he had CEO Garo on his show because he knows this is a blockbuster here.
#6 - Institutional investment coming in as this is over 5.00 range - just starting to build their positions. You can expect more money coming in very soon.
#7 - This is only the second day of the run - looking for 3 good days here.
#8 - This will be extremely volatile and is officially in play. There is quite a buzz here and you can expect runs throughout the day, both up and down but trending higher as more people believe in this as a long term investment and not a quick trade. I am looking at the 5.20 level as the floor but not quite sure how high this can or will go from here. I do believe this will eventually be much, much higher from here.
DREAM ON if you think this is opening under 5.00 on Monday. I would not want to have a short position going into the market opening, especially after Cramer's piece on CNBC that drove this up to almost 6.00 after hours.
-- Game changer news on Friday - not fluff news but with substance
-- Only second day of run
-- Several upgrades on Friday and almost certainly more to follow as news digests. All targeting over 10.00/share
-- Cramer's pump on CNBC along with putting the CEO Garo on to talk about the company's progress.
This stock is IN PLAY and should see a great deal of volatility as traders hammer the buy like they did mid-day when it reached 4.91 with an upgrade and will hammer the sell orders if it gets too high and buying dries up. Traders will be trying to play this both ways Monday, but trend should be higher. As far as opening price you can place your bets but I think you could see 7.00 very easily at some point, especially with added upgrades and/or news.
Agreed. You get the feeling this will run hard again soon.
very true!! I think this should be a very good buying opportunity right now and I am looking for some great things at the conference!
Me too - they don't let you present at this conference without having something very top shelf to display!!
I think this is a good thing - it should spark a little interest and put us out there at the conference. We should get some interest in the stock leading up to the conference as well! Good luck longs!
News out today
http://finance.yahoo.com/news/aethlon-medical-present-biotech-showcase-121500227.html
Aethlon Medical to Present at Biotech Showcase 2015
.
PR Newswire
Aethlon Medical, Inc.
33 minutes ago
?
?
?
?
. ?
?
?
.
..
.
.
SAN DIEGO, Jan. 8, 2015 /PRNewswire/ -- Aethlon Medical, Inc. (AEMD), the pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, today announced that James A. Joyce, Chief Executive Officer, will present at the Biotech Showcase 2015 Conference on Wednesday, January 14, 2015. Details of Aethlon Medical's presentation are as follows:
Event:
Biotech Showcase 2015
Date:
Wednesday, January 14, 2015
Time:
4:00 p.m. Pacific Time / 7:00 p.m. Eastern Time
Location:
Parc 55 Wyndham Union Square, San Francisco, CA
A live audio webcast of the presentation will be available on the Company's website (www.aethlonmedical.com) in the Investor Relations section on the Events and Presentations or can be accessed directly at http://edge.media-server.com/m/p/4cvayawf. The webcast replay will be available approximately two hours after the presentation ends and will be accessible for one month.
About Biotech Showcase 2015
The Biotech Showcase 2015 conference takes place January 12-14, 2015, at the Parc 55 Wyndham Hotel located in Union Square, San Francisco, California. Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences. Now in its seventh year, Biotech Showcase is expected to attract upwards of 1,500 attendees.
..
View photo
.Aethlon Hemopurifier.
About Aethlon Medical, Inc.
Aethlon Medical creates targeted therapeutic devices to address infectious disease, cancer and neurodegenerative disorders. The company's lead product is the Aethlon Hemopurifier®, a first-in-class device that selectively targets the rapid elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Exosome Sciences, Inc. is a majority owned subsidiary that is advancing exosome-based products to diagnose and monitor cancer, infectious disease and neurological disorders. For more information, please visit http://www.aethlonmedical.com/ and connect with the Company on Twitter, LinkedIn, Facebook and Google+.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the ESI will not be able to commercialize its future products, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy or as a broad spectrum defense against viral pathogens, including Ebola, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, the ability of the Company to meet the milestones contemplated in the DARPA contract, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
Aethlon Media Contact:
Leah-Michelle Nebbia (for interviews requests)
Golin
202-585-2651
lnebbia@golin.com
85 sticks - I think you are right. It's the same deal as Friday - looking for about the last hour to get things heating up. The MM's for this stock are testing the patience here and seeing if they can get people to unload cheap.
same action as Friday - watch it move again right toward the EOD.
Looking for at least .45 today enroute to .50 this week. Anything less is a strong buy. Hit the gaps - should make lots of money today if we play this right!
Not sure what tomorrow will bring. I do know there is a LOT of buzz here and many people will be watching. It is in play for tomorrow so volume will be heavy and there will probably be some pretty good price fluctuations on it. I have a feeling there will be a lot of buying on the dips or people selling then trying to get back in at a (hopefully) lower price. Lot of action tomorrow, that's for sure!
Reading market sentiment can be difficult but you have got to get good at it if you want to trade stocks. In the end, you need to buy something before the herd piles in and sell it before they do buying low and selling high (or vice versa) You can judge market sentiment from these boards but I have found an even better way is to read the tweets to see where the buzz is. Find some people to follow that are good at this and where their ideas lie.
Right now the buzz is there for AEMD and people are getting excited about it meaning more will pile in as soon as they can. If you are looking for an entry point, buy on the dip. Good luck here - I have made money on this one 2 different times and actually thought I was out for good the last time but I am back strong and I believe this time it runs back over .50 level and up to .72 point barring any bad news. Stay tuned, good luck and hope we both can make some good cash on this again!!
hopester - now you see - THAT was a reasonable post. People will listen and respect you for those kinds of posts.
We will see how this rally goes and how long it lasts. The proof and the truth will eventually come out. Either this works (and if it does - this goes absolutely ballistic!) or it is a fraud and goes to zero. Right now though - things are looking good and we have a little momentum so let's enjoy it while we can.
Who knows -- who cares? All I know is I made a lot of (paper) money yesterday and things bode well for a nice continued run. Sure looks good for another run over .50 this week and testing the .72 high in the very near future. Looking forward to Monday already!
Heading back into the 50's and beyond!! Remember - this stock hit .72 a while back -- and that was before being named one of the Time Magazine's best new inventions of 2014 and more importantly, before the FDA approval!! This just lessened the risk and raised the reward to unprecedented levels.
This is a true game changer folks - do not let them steal your shares cheap and buy on the dips. The final hour today was very strong buying in large blocks - the word is getting out and people want in! Hang in there longs - it's a great start to the new year but I feel the best is yet to come!!
Nice day! Looking for more as this has a long ways to run! Should continue it's climb through the CES (Consumer Electronics Show) Jan. 6th-Jan. 9th in Las Vegas as Quell will finally be unveiled and demonstrated. Very good volume, price action and chart today!
Not disgruntled but long gone. I had high hopes for it, but it wasn't meant to be. I will keep an eye on it, but I have seen this way too many times before in the sub-pennies
Nice strong upward trend! You can tell there was a little profit taking and some consolidation the last couple days, but this was just way too oversold to be down here much longer. Looking for 2-3 dollars near term! Good luck to all!!
See -- looks like we are hanging tough and moving up!!! Get on board and load up!!
Agreed, Tim. This is being touted as a strong bet by many people as one of the best opportunities to being a 10 bagger, including stockaholics and Penny stock secrets. ALL THEY ARE DOING IS LEAVING IT OPEN --BY VOTE-- to leave it as an option 4 months from now.